ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 134228 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 134228; 2) Community: the network communities that were significantly associated with the response to NSC 134228; 3) Molecule: the relationships between components within communities and NSC 134228; 4) MDR: the compounds that were significantly associated with the NSC 134228.

NSC Compound Enrichment Correlation
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0386895225700413 -0.13841048
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0386895225700413 0.073197913
NSC 180973 Tamoxifen citrate 0.0386895225700413 0.3219743
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0386895225700413 0.070017533
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0386895225700413 0.1259704
NSC 266491 Psorspermin 0.0386895225700413 0.45241201
NSC 279503 ISOBRUCEIN A 0.0386895225700413 0.42745272
NSC 299934 THAPSIA VILLOSA COMPD 0.0386895225700413 0.14833138
NSC 3060 Arsenenous acid, potassium salt (9CI) 0.0386895225700413 0.10930214
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0386895225700413 0.19794683
Total:126  Current:101    [First] [Prev] [Next] [Last]